Hospital & Healthcare Management December 14, 2023
Content Team HHMGlobal

Come to think of it there happen to be two contrasting trends in healthcare M&As that are seen today: one in the present, that is characterized by a reduced dealmaking, and the other in the future, wherein dealmakers go on to hold a growing positive outlook.

It is well to be noted that the deal data has seen a significant dip in its entirety since its peak in the latter half of 2021 and early 2022. This dip has been witnessed in the second as well as third quarters of 2023. It is quite significant to note that these figures could vary based on how deal data gets defined and who is going to report it.

2023 third quarter went...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Digital Health, Health System / Hospital, Mental Health, Mergers & Acquisitions / JV, Payment Models, Provider, Technology, Telehealth, Trends, Value Based
Boston Scientific to buy Intera Oncology, maker of liver cancer treatment
Halozyme abandons its €2bn pursuit of Evotec
M&A Cyber Success Depends on Communication, an Honest Evaluation of Each Side’s Strengths & Risks, and an Open Mind
Halozyme Pulls €2B Acquisition Bid as Evotec Commits to Standalone Strategy
Weekly HCRE Briefing: AdventHealth to Acquire Two CHS Hospitals in FL | Kaiser Acquiring ASCs and MOBs

Share This Article